PE anti-mouse CD223 (LAG-3) Antibody
- 产品名称：
- PE anti-mouse CD223 (LAG-3) Antibody
- 产品类别：
- 抗体
- 产品编号：
- 125207
- 产品应用：
- 125207
- Verified Reactivity
- Mouse
- Antibody Type
- Monoclonal
- Host Species
- Rat
- Immunogen
- Murine CD223-Ig fusion protein
- Formulation
- Phosphate buffered solution, pH 7.2, containing 0.09% sodium azide.
- Preparation
- The antibody was purified by affinity chromatography, and conjugated with PE under optimal conditions.
- Concentration
- 0.2 mg/ml
- Storage & Handling
- The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
- Application
-
FC - Quality tested
- Recommended Usage
Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤1.0 ?g per million cells in 100 ?l volume. It is recommended that the reagent be titrated for optimal performance for each application.
- Excitation Laser
- Blue Laser (488 nm)
Green Laser (532 nm)/Yellow-Green Laser (561 nm)
- Application References
(PubMed link indicates BioLegend citation) -
- Workman CJ, et al. 2002. Eur. Immunol. 32:2255. (IP, ELISA)
- Workman CJ, et al. 2005. J. Immunol. 174:688. (FC)
- Li N, et al. 2004. J. Immunol. 173:6806. (IP, ELISA)
- Product Citations
-
- Bertrand F, et al. 2017. Nat Commun. 8:2256. PubMed
- Logan K Smith et al. 2018. Immunity. 48(2):299-312 . PubMed
- Dong MB, et al. 2020. Cell. 178(5):1189-1204.e23.. PubMed
- Clement M, et al. 2016. PLoS Pathog. 12:e1006050. PubMed
- Lu SX, et al. 2021. Cell. . PubMed
- Yu AI, et al. 2020. Cell Rep. 107471:31. PubMed
- Rodriguez AB, et al. 2021. Cell Reports. 36(3):109422. PubMed
- Mitchell JE, et al. 2021. Cell Reports. 35(2):108966. PubMed
- Lv Z, et al. 2020. Oncoimmunology. 9:1747688. PubMed
- Wagle MV, et al. 2021. Nat Commun. 12:2782. PubMed
- Gozgit JM, et al. 2021. Cancer Cell. :. PubMed
- Hu Q, et al. 2018. Nat Biomed Eng. 0.660416667. PubMed
- Fortner K, et al. 2017. Journal of Autoimmunity. 10.1016/j.jaut.2017.05.003. PubMed
- Zuo S, et al. 2021. J Immunother Cancer. 9:. PubMed
- Shen M, et al. 2022. Nat Cancer. 3:60. PubMed
- RY H, et al. 2016. Oncoimmunology. 6:e1249561. PubMed
- Yang BH, et al. 2020. Cell Reports. 27(12):3629-3645.e6.. PubMed
- Wedekind MF, et al. 2021. iScience. 24(7):102759. PubMed
- Alenazy MF, et al. 2022. PLoS One. 17:e0271689. PubMed
- De Souza ALS, et al. 2018. Neurol Ther. 7:103. PubMed
- Lu Y, et al. 2018. Cancer Cell. 33:1048. PubMed
- Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
- Rudd CE, et al. 2020. Cell Reports. 30(7):2075-2082. PubMed
- RRID
- AB_2133344 (BioLegend Cat. No. 125207) AB_2133343 (BioLegend Cat. No. 125208)
